Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 6/20 | 0.70 |
| ▸ | CYP1B1 | Q16678 | 3/20 | 0.70 |
| ▸ | MAPT | P10636 | 3/20 | 0.70 |
| ▸ | BCHE | P06276 | 2/20 | 0.70 |
| ▸ | PLIN1 | O60240 | 1/20 | 0.70 |
| ▸ | LMNA | P02545 | 1/20 | 0.70 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.70 |
| ▸ | ACHE | P22303 | 1/20 | 0.70 |
| ▸ | RECQL | P46063 | 1/20 | 0.70 |
| ▸ | PLIN5 | Q00G26 | 1/20 | 0.70 |
| ▸ | ABHD5 | Q8WTS1 | 1/20 | 0.70 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.66 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.66 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.66 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.66 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.66 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.66 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.66 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.66 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11124806 | 1.00 | MAOB (0.70) | MAOBCYP1B1MAPTBCHEPLIN1 | |
| SCHEMBL6369083 | 0.91 | MAOB (0.72) | MAOBCYP1B1MAPTBCHEPLIN1 | |
| SCHEMBL16226002 | 0.91 | MAOB (0.72) | MAOBCYP1B1MAPTBCHEPLIN1 | |
| SCHEMBL30383945 | 0.91 | MAOB (0.72) | MAOBCYP1B1MAPTBCHEPLIN1 | |
| SCHEMBL11185107 | 0.89 | MAOB (0.69) | MAOBCYP1B1MAPTBCHEPLIN1 | |
| SCHEMBL11185094 | 0.89 | MAOB (0.69) | MAOBCYP1B1MAPTBCHEPLIN1 | |
| Chalcone SCHEMBL4385453 | 0.89 | CYP1B1 (0.88) | MAOBCYP1B1MAPTBCHEPLIN1 | |
| Chalcone SCHEMBL4385450 | 0.89 | CYP1B1 (0.88) | MAOBCYP1B1MAPTBCHEPLIN1 | |
| SCHEMBL13203405 | 0.89 | CYP1B1 (0.81) | MAOBCYP1B1MAPTBCHEPLIN1 | |
| SCHEMBL25214545 | 0.85 | CYP1B1 (0.81) | MAOBCYP1B1MAPTBCHEPLIN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4421927-A | SKIN DISORDERS | SOCIETE DE RECHERCHES INDUSTRIELLES (S.O.R.I.) (FR) | 1983-12-20 | — | — | US | claimed |
| EP-0051514-B1 | CINNAMOYL-CINNAMIC ACID DERIVATIVE, ITS PREPARATION AND ITS USE AS A THERAPEUTIC AGENT | SOCIETE DE RECHERCHES INDUSTRIELLES S.O.R.I. Société anonyme dite: (FR) | 1983-11-23 | — | — | EP | claimed |
| US-20140335050-A1 | METHODS, COMPOSITIONS, AND KITS FOR THE TREATMENT OF CANCER | THE GENERAL HOSPITAL CORPORATION (US) | 2014-11-13 | — | — | US | disclosed |
| US-4421927-A | SKIN DISORDERS | SOCIETE DE RECHERCHES INDUSTRIELLES (S.O.R.I.) (FR) | 1983-12-20 | — | — | US | disclosed |
| US-4421927-A | SKIN DISORDERS | SOCIETE DE RECHERCHES INDUSTRIELLES (S.O.R.I.) (FR) | 1983-12-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140335050-A1 | METHODS, COMPOSITIONS, AND KITS FOR THE TREATMENT OF CANCER | IL2RA, CD74, IL2 | MAOB 3038/4885CYP1B1 2200/4885MAPT 3619/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.